MAIT Cells Regulate Allogeneic T Cell Proliferation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Graft Versus Host Disease (GVHD) remains a significant complication following hematopoietic cell transplantation, with donor T cells often attacking host tissues, leading to inflammation and tissue damage, and current treatments rely on immunosuppressive agents that increase susceptibility to infections.
Innovation Solution
The use of Mucosal-Associated Invariant T cells (MAIT cells), which do not proliferate in response to allogeneic stimulation and require inflammatory and TCR ligation for expansion, are administered to control GVHD by inhibiting the proliferation of alloreactive T cells, thereby reducing tissue damage.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If donor T cells are used to eliminate residual tumor cells (GVL effect), then therapeutic effect is improved, but graft-versus-host disease (GVHD) occurs due to recognition and attack of normal host tissues
Solution Approach 1:
MAIT cells serve as intermediary regulatory cells that mediate between donor T cells and host tissues. They suppress the harmful alloreactive response of donor T cells against host tissues while permitting the beneficial GVL effect, thereby resolving the contradiction between therapeutic efficacy and tissue damage
Solution Approach 2:
The invention changes the immunological parameter balance by introducing MAIT cells that alter the cytokine environment and suppressive milieu, shifting the system from a state of harmful alloreactivity to one where donor T cells can eliminate tumor cells without causing severe GVHD
2Object-generated harmful factors
If immunosuppressive agents are used to treat GVHD, then tissue damage is reduced, but susceptibility to infections increases
Solution Approach 1:
The invention converts the harmful effect of immunosuppression into a beneficial selective approach: instead of broadly suppressing all immune responses (which increases infection risk), MAIT cells specifically regulate donor T cell alloreactivity while preserving host immune defenses against infections
Solution Approach 2:
MAIT cells act as a targeted intermediary that specifically modulates the donor-host immune interaction without causing broad immunosuppression, thereby reducing tissue damage while maintaining protective immunity against opportunistic infections
Data Source
AI summary
The inventors explored in an allogeneic situation the regulatory potential of Mucosal-Associated Invariant T cells (MAIT cells), a population of unconventional T cells that exhibit potent antibacterial activity, expressing a semi-invariant TCR which recognizes vitamin B2 derivatives of microbial origin presented by the MR1 molecule. In particular, the inventors used i) an allogenic reaction model in vitro (mixed lymphocyte reaction, MLR) and ii) murine model of xenogeneic aGvHD They first verified that human MAIT cells do not proliferate in response to allogeneic stimulation in vitro (MLR) or in vivo (immunodeficient mice) alone but require for their expansion both an inflammatory environment and TCR ligation by its ligand. In contrast, MAIT cells are able to inhibit the proliferation of allospecific LT in vitro in a dose-dependent manner. Furthermore, the adoptive transfer of MAIT cells in a mouse model of xeno-GVHD resulted in a delay in early or late GvHD development. Altogether, these data describe a new regulatory function of MAIT cells in an allogeneic context, allowing us to consider their use in cell therapy to limit GvHD.